The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Akbari M, Ostadmohammadi V, Tabrizi R, Lankarani KB, Heydari ST, Amirani E
Published in Metabolism, Vol. 87, pp. 56-69
Methodology
Meta-analysis of randomized trials of alpha-lipoic acid reporting fasting glucose, insulin and HOMA-IR.
Key Findings
Alpha-lipoic acid significantly reduced fasting insulin and HOMA-IR, indicating improved insulin-mediated substrate handling.
Conclusions
Alpha-lipoic acid improves insulin sensitivity, an upstream determinant of metabolic flexibility.
Limitations
Populations mostly metabolic disease; heterogeneity in dosing.
Supplements Studied
Alpha-lipoic acid significantly reduced fasting insulin and HOMA-IR
Outcomes Measured
Alpha-lipoic acid significantly reduced fasting insulin and HOMA-IR
Alpha-lipoic acid significantly reduced fasting insulin and HOMA-IR, indicating improved insulin-mediated substrate handling.
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.